2022 Q4 Form 10-Q Financial Statement

#000165495422016558 Filed on December 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q4
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $51.65K
YoY Change 0.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $51.65K
YoY Change 0.3%
Operating Profit -$51.65K
YoY Change 0.3%
Interest Expense $1.585K
YoY Change -20.11%
% of Operating Profit
Other Income/Expense, Net -$104.00
YoY Change
Pretax Income -$51.76K
YoY Change -3.22%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$51.76K
YoY Change 81.55%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$627.30
COMMON SHARES
Basic Shares Outstanding 87.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.790K
YoY Change -85.17%
Cash & Equivalents $2.791K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.791K
YoY Change -85.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.791K
Total Long-Term Assets $0.00
Total Assets $2.791K
YoY Change -85.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.51K
YoY Change 9.85%
Accrued Expenses $307.0K
YoY Change -10.22%
Deferred Revenue
YoY Change
Short-Term Debt $79.00K
YoY Change -32.6%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $489.9K
YoY Change -11.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $489.9K
Total Long-Term Liabilities $0.00
Total Liabilities $489.9K
YoY Change -11.27%
SHAREHOLDERS EQUITY
Retained Earnings -$3.443M
YoY Change 3.58%
Common Stock $82.51K
YoY Change 8.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$487.1K
YoY Change
Total Liabilities & Shareholders Equity $2.791K
YoY Change -85.17%

Cashflow Statement

Concept 2022 Q4
OPERATING ACTIVITIES
Net Income -$51.76K
YoY Change 81.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$23.02K
YoY Change -54.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$23.02K
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00
Net Change In Cash -$23.02K
YoY Change -229.0%
FREE CASH FLOW
Cash From Operating Activities -$23.02K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
34400 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
28400 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Cash
Cash
2791 usd
CY2022Q3 us-gaap Cash
Cash
25813 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2791 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
25813 usd
CY2022Q4 us-gaap Assets
Assets
2791 usd
CY2022Q3 us-gaap Assets
Assets
25813 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
69513 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48364 usd
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001415744
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Entity Address Country
EntityAddressCountry
CA
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87509357 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82509357 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87509357 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-10-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
333-146934
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
NORTHERN MINERALS & EXPLORATION LTD.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0557171
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
881 West State Road
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Pleasant Grove
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84062
CY2022Q4 dei City Area Code
CityAreaCode
801
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
885-9260
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87509357 shares
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
306998 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
305413 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
79000 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
79000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
489911 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
461177 usd
CY2022Q4 us-gaap Liabilities
Liabilities
489911 usd
CY2022Q3 us-gaap Liabilities
Liabilities
461177 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82509357 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
82509 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
82509 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2873468 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2873468 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3443097 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3391341 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-487120 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-435364 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2791 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25813 usd
CY2022Q4 us-gaap Officers Compensation
OfficersCompensation
6600 usd
CY2021Q4 us-gaap Officers Compensation
OfficersCompensation
6600 usd
CY2022Q4 ndm Consulting Related Party
ConsultingRelatedParty
18000 usd
CY2021Q4 ndm Consulting Related Party
ConsultingRelatedParty
15000 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
16500 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
19450 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10552 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10447 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
51652 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
51497 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-51652 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-51497 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
1585 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
1984 usd
CY2022Q4 us-gaap Other Income
OtherIncome
1481 usd
CY2021Q4 us-gaap Other Income
OtherIncome
0 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1984 usd
CY2022Q4 us-gaap Income Loss From Subsidiaries Before Tax
IncomeLossFromSubsidiariesBeforeTax
-51756 usd
CY2021Q4 us-gaap Income Loss From Subsidiaries Before Tax
IncomeLossFromSubsidiariesBeforeTax
-53481 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51756 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-53481 usd
CY2022Q4 ndm Net Loss Per Share From Operations Basic And Diluted
NetLossPerShareFromOperationsBasicAndDiluted
-0.00
CY2021Q4 ndm Net Loss Per Share From Operations Basic And Diluted
NetLossPerShareFromOperationsBasicAndDiluted
-0.00
CY2022Q4 ndm Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
82509357 shares
CY2021Q4 ndm Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
74510229 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-596223 usd
CY2021Q4 ndm Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
5000 usd
CY2021Q4 ndm Common Stock Issued For Cash Related Party Amount
CommonStockIssuedForCashRelatedPartyAmount
63000 usd
CY2021Q4 ndm Common Stock Issued For Conversion Of Debt And Accrued Interest Amount
CommonStockIssuedForConversionOfDebtAndAccruedInterestAmount
48400 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-53481 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-533304 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-435364 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51756 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-487120 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51756 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-53481 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21149 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6345 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
6000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-5000 usd
CY2022Q4 ndm Increase Decrease In Accounts Payable And Accrued Liability
IncreaseDecreaseInAccountsPayableAndAccruedLiability
1585 usd
CY2021Q4 ndm Increase Decrease In Accounts Payable And Accrued Liability
IncreaseDecreaseInAccountsPayableAndAccruedLiability
1983 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23022 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50153 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q4 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2021Q4 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5000 usd
CY2022Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
CY2021Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5000 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
68000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-23022 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17847 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25813 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
967 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2791 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18814 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 ndm Conversion Of Debt And Accrued Interest
ConversionOfDebtAndAccruedInterest
0 usd
CY2021Q4 ndm Conversion Of Debt And Accrued Interest
ConversionOfDebtAndAccruedInterest
48400 usd
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2022Q4 ndm Interest
interest
0.24 pure
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1911330 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3443097 usd
CY2019Q1 ndm Acquisition Percentage
AcquisitionPercentage
0.80 pure
CY2022Q4 ndm Accrued Liabilities Winnemucca
AccruedLiabilitiesWinnemucca
285453 usd
CY2022Q3 ndm Accrued Liabilities Winnemucca
AccruedLiabilitiesWinnemucca
285453 usd
CY2021 ndm Reduction In The Liabilities
ReductionInTheLiabilities
285453 usd
CY2022Q4 ndm Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
23616 usd
CY2022Q4 ndm Repayment Of Loan
RepaymentOfLoan
15000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14795 usd
CY2022Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5000000 shares

Files In Submission

Name View Source Status
0001654954-22-016558-index-headers.html Edgar Link pending
0001654954-22-016558-index.html Edgar Link pending
0001654954-22-016558.txt Edgar Link pending
0001654954-22-016558-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ndm-20221031.xsd Edgar Link pending
nmex_10q.htm Edgar Link pending
ndm-20221031_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ndm-20221031_lab.xml Edgar Link unprocessable
ndm-20221031_pre.xml Edgar Link unprocessable
ndm-20221031_cal.xml Edgar Link unprocessable
nmex_10q_htm.xml Edgar Link completed
nmex_ex311.htm Edgar Link pending
nmex_ex312.htm Edgar Link pending
nmex_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending